Cases 51 - 60 of 1,147
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00050
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al
as 1:2023cv01372
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff:
AbbVie Inc.
Defendant:
Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2023cv01459
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Harmony Biosciences, LLC et al v. AET Pharma US, Inc. et al
as 1:2023cv01340
Plaintiff:
Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche and Bioprojet Pharma SAS
Defendant:
AET Pharma US, Inc., Annora Pharma Private Limited, Hetero USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2023cv01268
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Novugen Oncology Sdn. Bhd. et al
as 1:2023cv01449
Plaintiff:
Novartis Pharmaceuticals Corporation, Novartis Pharma AG and Japan Tobacco Inc.
Defendant:
Novugen Oncology Sdn. Bhd., Novugen Pharma (USA) LLC and Makro Technologies, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Astrazeneca AB et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv01457
Plaintiff:
Astrazeneca AB and AstraZeneca Pharmaceuticals LP
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Harmony Biosciences, LLC et al v. Lupin Limited et al
as 1:2023cv01286
Plaintiff:
Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche and Bioprojet Pharma SAS
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Novugen Pharma Sdn. Bhd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
as 1:2023cv01195
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Meitheal Pharmaceuticals, Inc. and Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
